[Keratinocyte growth factor and its receptor in middle-ear cholesteatoma].

Otolaryngol Pol

Zakład Patomorfologii Ogólnej Uniwersytetu Medycznego w Białymstoku, Poland.

Published: July 2013

Aim: Etiology of middle ear cholesteatoma is far from beeing elicidated. Current concepts postulate that cholesteatoma is the result of disturbed wound healing process. Keratinocyte growth factor (KGF) plays important role in wound healing, so it seemed interesting to assess the expression of KGF and its receptor in the cholesteatoma.

Material And Methods: 25 cholesteatoma and 7 retraction pockets specimens were obtained from the patients during middle ear surgery. The expression of KGF and FGFR2 was evaluated by immunohistochemical staining using polyclonal antibodies. The results were analyzed depending on clinical features such as: localization, number of anatomic sites involved and presence of purulent discharge.

Results: KGF expression was detected in the cells of subepithelial tissue. It was observed in 4/7 (57%) of the specimens of retraction pockets and 11/25 (44%) of cholesteatoma specimens. FGFR2 expression was observed mainly in the cells of spinous layer of epithelium in 4/7 (57%) specimens of retraction pockets and 19/25 (76%) of specimens of cholesteatoma. Statistically significant (p=0.011) relationship between the presence of KGF expression in the subepithelial tissue and the presence of FGFR2 expression in the epithelium was found. There were no differences in the expression of KGF and FGFR2 between retraction pocket and cholesteatoma specimens. Also, no differences in the expression, depending on localization, extend of the cholesteatoma and presence of purulent discharge were observed.

Conclusion: KGF and its receptor seem to play an important role in paracrine regulation of cholesteatoma growth.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.otpol.2012.11.002DOI Listing

Publication Analysis

Top Keywords

expression kgf
12
retraction pockets
12
growth factor
8
middle ear
8
cholesteatoma
8
wound healing
8
expression
8
kgf receptor
8
kgf fgfr2
8
presence purulent
8

Similar Publications

Mutations in the SLC25A38 gene are responsible for the second most common form of congenital sideroblastic anemia (CSA), a severe condition for which no effective treatment exists. We developed and characterized a K562 erythroleukemia cell line with markedly reduced expression of the SLC25A38 protein (A38-low cells). This model successfully recapitulated the main features of CSA, including reduced heme content and mitochondrial respiration, increase in mitochondrial iron, ROS levels and sensitivity to oxidative stress.

View Article and Find Full Text PDF

Objective: Diabetes mellitus (DM) delays wound healing, including those following tooth extractions. Curcumin (CCM) can promote soft tissue and bone healing. The present study investigates the healing effects of CCM on tooth extraction sockets in diabetic rats.

View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses the use of a traditional medicine for healing skin wounds, highlighting its unclear mechanisms but focusing on how it promotes cell growth and movement during wound healing.
  • - It details how this medicine increases various growth factors and proteins crucial for skin repair while decreasing harmful enzymes that break down the extracellular matrix.
  • - Although there have been positive human trials showing its effectiveness for wound healing and skin conditions, most current commercial applications are limited to cosmetic products, indicating a need for expanded clinical use.
View Article and Find Full Text PDF

In our present study, we investigated the interaction between HSCs and HCC, also explored the molecular mechanism. Clinical samples were collected from HCC and adjacent tissue with different degree of liver fibrosis. HCC cells were co-cultured with LX-2 cell by Transwell system or cultured with conditioned medium (CM), which was collected from LX-2.

View Article and Find Full Text PDF

Mesenchymal stem cell (MSC)-derived exosomes (EXs) have emerged as promising therapeutic agents for wound healing. However, the optimal conditions for manufacturing MSC-derived EXs that maximize their wound-healing potential have yet to be established. Hence, we compared the efficacy of five different MSC culture media, including three different serum-free, a platelet-supplemented, and a fetal bovine serum-supplemented media, in exosome manufacturing for wound healing applications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!